Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-167,142	Closed	-$14.9M	–	81
2023 Q4	$14.9M	Hold	167,142	–	–	1.02%	34
2023 Q3	$12.4M	Hold	167,142	–	–	0.91%	33
2023 Q2	$13.9M	Hold	167,142	–	–	0.98%	33
2023 Q1	$12.5M	Buy	167,142 +139,645	+508%	+$11.6M	1.01%	37
2022 Q4	$2.27M	Hold	27,497	–	–	0.19%	81
2022 Q3	$2.17M	Hold	27,497	–	–	0.18%	85
2022 Q2	$2.02M	Hold	27,497	–	–	0.16%	85
2022 Q1	$2.45M	Hold	27,497	–	–	0.17%	82
2021 Q4	$3.08M	Hold	27,497	–	–	0.2%	88
2021 Q3	$3.46M	Hold	27,497	–	–	0.25%	82
2021 Q2	$3.72M	Buy	27,497 +1,097	+4%	+$144K	0.27%	80
2021 Q1	$3.58M	Sell	26,400 -1,097	-4%	-$164K	0.36%	58
2020 Q4	$3.87M	Buy	27,497 +1,097	+4%	+$141K	0.36%	60
2020 Q3	$2.94M	Hold	26,400	–	–	0.34%	52
2020 Q2	$2.96M	Hold	26,400	–	–	0.43%	51
2020 Q1	$2.51M	Hold	26,400	–	–	0.6%	48
2019 Q4	$2.51M	Buy	26,400 +895	+4%	+$77.4K	0.58%	50
2019 Q3	$2.31K	Hold	25,505	–	–	0.36%	49
2019 Q2	$2.31M	Hold	25,505	–	–	0.65%	44
2019 Q1	$2.31M	Hold	25,505	–	–	0.78%	39
2018 Q4	$1.83M	Buy	+25,505	New	+$2.05M	0.59%	44

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's XBI Position: Q1 2024 in Review

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 167,142 shares — an estimated $14.9M sold.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in XBI in Q4 2018 and held it in 21 quarters. The position peaked at $14.9M in Q4 2023. 781 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold 167,142 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $14.9M.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 21 quarters.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's State Street SPDR S&P Biotech ETF position peaked at $14.9M in Q4 2023.
781 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's 13F filing for Q1 2024, filed 1 May 2024.